Skip to main content

Table 2 Means, standard deviations, floor and ceiling percentages, skewness, kurtosis, and I-T correlation of the Japanese version of the Barriers Questionnaire-II (total sample)

From: Validation of the Japanese version of the barriers questionnaire II in cancer pain management: a cross-sectional study

No

Items

Mean(SD)

Floor (%)

Celling (%)

Skewness

Kurtosis

I-Ta

correlation

1

Fatalism 1

0.97

(0.94)

38.33

1.67

0.74

0.22

0.27**

2

Harmful Effects: Addiction 1

2.81

(1.42)

7.50

10.00

− 0.43

− 0.66

0.48**

3

Physiological Effects: SE1 (Drowsiness)

2.78

(1.36)

8.33

7.50

−0.49

−0.45

0.32**

4

Harmful Effects: Immune system 1

2.23

(1.51)

21.67

4.17

−0.20

−1.11

0.69**

5

Physiological Effects: SE2 (Confusion)

2.23

(1.46)

19.17

4.17

−0.17

− 0.97

0.71**

6

Physiological Effects: Tolerance 1

3.21

(1.31)

4.17

12.50

−0.81

0.02

0.61**

7

Physiological Effects: Monitor 1

2.64

(1.52)

11.67

11.67

−0.23

−0.90

0.61**

8

Fatalism 2

1.33

(1.28)

28.33

5.00

1.23

1.47

0.11

9

Harmful Effects: Addiction 2

2.55

(1.46)

14.17

6.67

−0.36

−0.76

0.57**

10

Physiological Effects: SE3 (Nausea)

1.98

(1.32)

15.83

3.33

0.16

−0.67

0.44**

11

Communication: Be good 1

1.32

(1.61)

50.00

6.67

0.92

−0.38

0.41**

12

Communiation: Distract MD 1

0.74

(1.18)

62.50

1.67

1.65

2.11

0.48**

13

Harmful Effects: Immune system 2

2.10

(1.52)

23.33

5.00

−0.04

−1.10

0.69**

14

Physiological Effects: SE4 (Embarrassment)

0.79

(1.10)

56.67

0.83

1.31

1.02

0.48**

15

Physiological Effects: Tolerance 2

2.53

(1.48)

12.50

8.33

−0.19

−0.90

0.59**

16

Physiological Effects: Monitor 2

2.37

(1.47)

15.83

6.67

−0.16

− 0.87

0.68**

17

Physiological Effects: SE5 (Constipation)

1.90

(1.48)

25.00

5.83

0.25

−0.81

0.57**

18

Communication: Distract MD 2

0.86

(1.23)

56.67

2.50

1.51

1.81

0.54**

19

Harmful Effects: Immune system 3

1.85

(1.48)

27.50

4.17

0.20

−0.99

0.70**

20

Physiological Effects: SE6 (general item)

1.52

(1.49)

35.83

5.00

0.64

−0.61

0.43**

21

Physiological Effects: Tolerance 3

1.76

(1.50)

25.83

5.00

0.47

−0.84

0.72**

22

Physiological Effects: Monitor 3

2.36

(1.58)

17.50

10.00

−0.04

−1.06

0.78**

23

Harmful Effects: Addiction 3

2.54

(1.51)

12.50

9.17

−0.19

− 0.94

0.74**

24

Fatalism 3

1.05

(1.15)

35.83

3.33

1.62

3.15

0.14

25

Communication: Be good 2

0.91

(1.27)

57.50

0.83

1.20

0.31

0.53**

26

Communication: Distract MD 3

0.68

(1.04)

60.83

0.83

1.74

3.00

0.51**

27

Communication: Be good 3

1.21

(1.45)

46.67

2.50

1.00

−0.16

0.32**

28

Disease Progression 1

3.30

(1.26)

3.33

18.33

−0.64

0.15

0.25**

29

Disease Progression 2

3.40

(1.18)

1.67

20.00

−0.55

0.11

0.36**

30

Disease Progression 3

3.24

(1.15)

0.83

15.00

−0.32

−0.27

0.37**

  1. aItem-total correlation **P < 0.01